Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
35 studies found for:    " November 05, 2008":" December 05, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" November 05, 2008":" December 05, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus
Conditions: Dry Eye Syndromes;   HIV Seropositivity
Interventions: Drug: cyclosporine and sodium carboximethycellulose;   Drug: sodium carboximethycellulose
2 Completed
Has Results
Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
Conditions: Cardiovascular Disease;   HIV Infection
Interventions: Drug: Lovaza;   Drug: Placebo
3 Enrolling by invitation Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
Conditions: HIV Infections;   AIDS;   Opportunistic Infections
Intervention:
4 Completed Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection
Conditions: Staphylococcus Aureus;   HIV Infections
Interventions: Drug: Mupirocin calcium ointment, 2%;   Drug: Placebo ointment
5 Active, not recruiting Micronutrients and Antioxidants in HIV Infection
Condition: HIV Infection
Interventions: Dietary Supplement: Micronutrients and antioxidants;   Dietary Supplement: Multivitamins and minerals
6 Recruiting Antiretroviral Therapy for Acute HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: HAART;   Drug: Mega-HAART
7 Active, not recruiting An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: Maraviroc
8 Completed A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults
Conditions: Human Immunodeficiency Virus;   Human Papillomavirus- 6, 11, 16, 18;   Adolescent;   Papillomavirus Vaccines
Interventions: Biological: Gardisil;   Behavioral: Survey
9 Completed Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daily Valacyclovir in the Reduction of HSV-2 Recurrence and Viral Shedding
Conditions: HSV-2;   HIV;   HIV Infections
Interventions: Drug: Valacyclovir;   Drug: Placebo
10 Recruiting Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials
Conditions: HIV Infection;   HIV Seronegativity
Intervention:
11 Recruiting Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
Condition: Acute HIV Infection
Intervention:
12 Completed Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)
Condition: HIV
Intervention: Biological: Dendritic Cell Vaccine
13 Completed Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults
Conditions: Malaria;   HIV
Interventions: Drug: Artemether/Lumefantrine;   Drug: Artemether/ lumefantrine
14 Unknown  Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM)
Conditions: Buprenorphine;   HIV;   Drug Abuse;   Drug Addiction;   Drug Dependence;   Drug Use Disorders;   Drug Use Disorder;   Substance Abuse;   Opiate Addiction;   Substance-Related Disorders
Interventions: Other: Services will be provided at one site;   Other: Services remain dispersed; i.e., not centralized to one-location or provider.
15 No longer available A Compassionate Access Protocol For Those Patients Who Have Completed A4001029
Condition: HIV
Intervention: Drug: Maraviroc
16 Unknown  The SASA! Study: An Evaluation of a Community Intervention to Address Gender-based Violence and Reduce HIV/AIDS Risk in Uganda
Conditions: Intimate Partner Violence;   HIV
Interventions: Behavioral: SASA!;   Other: Control
17 Completed Directly Observed Therapy for Community-Released HIV+ Prisoners
Conditions: HIV/AIDS;   Substance Abuse
Intervention: Behavioral: Directly administered antiretroviral therapy
18 Active, not recruiting A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of TMC278 in Human Immunodeficiency Virus Infected Adolescents
Condition: Human Immuno Deficiency (HIV) Infections
Interventions: Drug: TMC278;   Drug: Zidovudine;   Drug: Abacavir;   Drug: Tenofovir disoproxil fumarate;   Drug: Lamivudine;   Drug: Emtricitabine
19 Unknown  Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression
Condition: HIV Infection
Intervention: Drug: resume raltegravir
20 Unknown  Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia
Conditions: HIV Infection;   Hemophilia A
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Indicates status has not been verified in more than two years